Good MorningEquity markets tread water this week while traders waited for the May PCE price index to be released. The data is expected to be hot, but it may not matter. The market action suggested the rally would continue with or without a cooler read on inflation, opening up additional risk. The Fed suggests that more than 1 and even more than 2 more rate hikes are needed and that there could be 2 back to back hikes this summer.
As always, the earnings outlook will drive the S&P 500 this year. As it is, the market continues to expect a return to growth in the back half. So long as that remains in the picture, the market should be able to claw its way higher. The question is how high it can go. The Fed is on track to tighten the screws again, possibly leading to more bank failures and the recession hovering on the horizon for the last 12 months. Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Markets | |
Shares of Rite Aid (NYSE: RAD) have been on a sluggish path to becoming a near-penny stock, despite being one of the most entrenched brands in American Households. This name has become synonymous with children's 'boo boos' and first-aid kits. Indeed there is some hidden value to be had in the inta... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Technology | |
Paychex (NASDAQ: PAYX) shares are up more than 140% from the 2020 lows, but it may be time to ring the register. The Q4 results and outlook are good enough but failed to spark a rally in the stock. The post-release action shows significant resistance at the 150-day moving average suggesting the do... Read the Full Story |
|
Technology | |
Micron Technologies (NASDAQ: MU) has been suffering through an inventory correction that has yet to run its course, but a reversal in share prices is imminent. The Q3 results, as bad as they were, were better than expected and point to stabilization within the market. The bad times aren’t ov... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Markets | |
If the insider activity in Topgolf Calloway Brands (NYSE: MODG) can be used as a guide, the golf stock can indeed crawl out of its bunker, regain the fairway, and rally to score value for shareholders. The insiders started ramping up their activity late last year and have been buying the stock on ... Read the Full Story |
|
Consumer Staples | |
McCormick's (NYSE: MKC) price action wobbled following a better-than-expected Q2 and increased guidance. The news proves that the decision to transition Brenden Foley into the CEO position was good. The transition, begun in June 2022, was completed at the end of the quarter, leaving Mr. Brenden in... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Consumer Staples | |
For The Boston Beer Company, Inc. (NYSE: SAM) shareholders, the last two years have been far from a Boston Tea Party. Maybe it relates to the Bruins, Celtics, Patriots and Red Sox teams’ collective failure to bring home a sports championship. More likely, it's because the brewer has missed W... Read the Full Story |
|
Consumer Discretionary | |
Ding, ding, ding! A heated stock battle is underway with boutique gym franchisor Xponential Fitness, Inc. (NYSE: XPOF) at the center of the ring.
In the red corner — bearish short selling firm Fuzzy Panda. And in the green corner — bullish Wall Street analysts.
On Tuesday, the firs... Read the Full Story |
|
Consumer Staples | |
Analysts at Stephens, Bank of America (NYSE: BAC), and other stock price rating departments have taken on a less optimistic viewpoint regarding Cal-Maine (NASDAQ: CALM). Shares of Cal-Maine are trading slightly lower during the after-market hours of Wednesday evening, showcasing an initial decline... Read the Full Story |
|
Transportation | |
Shares of Old Dominion Freight Line inc. (NASDAQ: ODFL) just keep on truckin’ higher. As of June 28, stock of the less-than-truckload (LTL) specialist is up 13.49% for the week,
A catalyst for the move came in the form of two analyst upgrades on June 77. MarketBeat’s Old Dominion F... Read the Full Story |
|
Technology | |
Nvidia Corp.’s (NASDAQ: NVDA) meteoric year-to-date increase of 186.60% is largely due to the company’s semiconductors that are behind the boom in artificial intelligence applications.
But concerns about exactly those capabilities sent shares lower in recent days, as the U.S. Commerc... Read the Full Story |
|
Friday's Early Bird Stock Of The Day MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland. | | View Today's Stock Pick |
|
